Search research articles
Contact Us
Filters
Showing results (121-130 of 144) with videos related to
Page
of 15
Sort By:
Mabs
|
June 2, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab <i>in vitro</i>
Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Chest
|
April 12, 2007
Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease
Aryeh Fischer, Shigeki Misumi, Douglas Curran-Everett, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab <i>in vitro</i>
Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Chest
|
April 5, 2014
Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia
Matthew J Strand, David Sprunger, Gregory P Cosgrove, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 17, 2013
Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody
Christopher A Czaja, Patricia A Merkel, Edward D Chan, et al.
Chest
|
April 28, 2009
Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis
Jeffrey J Swigris, Jeff Swick, Frederick S Wamboldt, et al.
Respiratory Medicine
|
June 6, 2009
Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
Aryeh Fischer, Jeffrey J Swigris, Roland M du Bois, et al.
Respirology (Carlton, Vic.)
|
June 16, 2010
A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes
Tristan J Huie, Amy L Olson, Gregory P Cosgrove, et al.
Cell Research
|
April 24, 2021
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2
Haolin Liu, Qianqian Zhang, Pengcheng Wei, et al.
Biorxiv : the Preprint Server for Biology
|
August 31, 2021
The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 144) with videos related to
Sort By:
Page
of 15
Mabs
|
June 2, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab <i>in vitro</i>
Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Chest
|
April 12, 2007
Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease
Aryeh Fischer, Shigeki Misumi, Douglas Curran-Everett, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab <i>in vitro</i>
Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Chest
|
April 5, 2014
Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia
Matthew J Strand, David Sprunger, Gregory P Cosgrove, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 17, 2013
Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody
Christopher A Czaja, Patricia A Merkel, Edward D Chan, et al.
Chest
|
April 28, 2009
Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis
Jeffrey J Swigris, Jeff Swick, Frederick S Wamboldt, et al.
Respiratory Medicine
|
June 6, 2009
Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
Aryeh Fischer, Jeffrey J Swigris, Roland M du Bois, et al.
Respirology (Carlton, Vic.)
|
June 16, 2010
A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes
Tristan J Huie, Amy L Olson, Gregory P Cosgrove, et al.
Cell Research
|
April 24, 2021
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2
Haolin Liu, Qianqian Zhang, Pengcheng Wei, et al.
Biorxiv : the Preprint Server for Biology
|
August 31, 2021
The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Page
of 15